Market Research Logo

Healthcare Contract Research Organization (CRO) Market Analysis Report By Type (Clinical, Drug Discovery, Pre-Clinical), By Service (Clinical Monitoring, Regulatory Affairs), And Segment Forecasts, 2018 - 2025

Healthcare Contract Research Organization (CRO) Market Analysis Report By Type (Clinical, Drug Discovery, Pre-Clinical), By Service (Clinical Monitoring, Regulatory Affairs), And Segment Forecasts, 2018 - 2025

The global healthcare contract research organization (CRO) market size market is anticipated to reach USD 54.7 billion by 2025, according to a new study by Grand View Research Inc., rising at a CAGR of over 6.6.% during the forecast period. Increasing drug development cost is projected to propel the market over the forecast period. With growing number of patents expiring, increasing number of partnerships to identify biologics & new compounds, and rising R&D costs, drug makers and sponsor companies are under pressure to replace revenue loss specifically due to generics. This has further made drug development more expensive and complex, thereby augmenting the need for healthcare CRO services.

Regulatory framework for drug discovery and development is complex in various countries. Thus, an increasing need for expertise in different areas of drug development is driving the demand for outsourcing services. Drug companies are not only outsourcing production of medicines, but also clinical trials. With increasing privatization of clinical trials, there has been an increase in outsourcing of manufacturing processes to developing countries such as India, China, and Latin American countries.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing of research activities. Even government organizations are outsourcing their clinical trial activities to CROs so that they can carry out clinical trials with required infrastructure, expertise, and minimize cost and timelines. In 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI).

CROs are focusing on continuously improving their portfolio by integrating services with technology. This enables them to save more on time and deliver efficient and desired results to clients. In June 2016, LSK Global Pharma Services Co., Ltd. expanded the use of Medidata Clinical Cloud by Medidata Clinical Solutions, Inc. The former was established in 2000 and conducts clinical trials at both local and global scale. It utilizes Medidata’s electronic data capture, unified randomization, and medical coding solution and trial management supply solution.

Some of the key players in the market are Quintiles, Covance, Pharmaceutical Product Development, LLC (PPD), Parexel, Charles River Laboratories (CRL), ICON plc, inVentiv Health, and Medidata Solutions. Collaborations and acquisitions are among major strategies adopted by market players to stay ahead. In September 2017, Laboratory Corporation of America Holdings acquired Chiltern in a transaction worth USD 1.2 billion. Chiltern became a part of LabCorp’s Covance Drug Development business unit.

Further key findings from the study suggest:

  • Clinical trial services dominated the market in 2017, owing to the fact that it comprises four elaborate phases including human subjects. Increasing complexities in R&D trends are raising the need for expertise, thereby shortening the time required to commercialize the molecule
  • In January 2016, Charles River Laboratories International, Inc. entered into a definitive agreement to acquire WIL Research for approximately USD 585 million. The acquisition is expected to strengthen Charles River Laboratories ability to partner with global clients
  • High R&D spending in oncology has also fueled the need for healthcare contract research outsourcing
  • Asia Pacific was the largest regional market in 2017 and accounted for more than 35.0% due to reduced service cost it offers as compared to the U.S and other developed economies.
  • Increasing incidence rate of chronic and lifestyle diseases such as cardiac disorders and diabetes coupled with ease in patient recruitment and available expertise for clinical trials have been providing a boost to the market in APAC
  • China and India are projected to witness tremendous growth in the healthcare contract research outsourcing market owing to presence of a wide patient pool coupled with high disease prevalence rate
  • North America also commanded a sizeable share in the market in 2017 owing to presence of global players and healthcare giants. In addition, several academic institutes receive grants to undertake these activities. For instance, in July 2015, the University of Toronto received USD 1.5 billion under the Medicine by Design initiative.
Please note The report will be updated with the latest data and delivered to you within 3-4 business days.


Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Patent cliff
3.1.1.2 Increasing mergers and collaborations
3.1.1.3 Increasing adoption of advanced technologies
3.1.1.4 Increasing outsourcing of R&D activities
3.1.1.5 Favorable environment for clinical trials in developing countries
3.1.2 Market restraint analysis
3.1.2.1 Quality issues of CRO services
3.1.2.2 Intellectual property rights issues
3.2 Penetration & Growth Prospects Mapping
3.3 Healthcare CRO Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
3.5 Healthcare CRO Market Competitive Landscape: Market Position Analysis
3.6 Healthcare Contract Research Organization (CRO) Market Share, 2017
3.7 Healthcare CRO Market: Qualitative Analysis of Models
3.7.1 Transactional relationships
3.7.2 Functional service providers
3.7.3 Alliances
Chapter 4 Healthcare CRO Market: Type Estimates & Trend Analysis
4.1 Healthcare CRO Market: Type Movement Analysis
4.2 Drug Discovery
4.2.1 Drug discovery market, 2014 - 2025 (USD Million)
4.2.2 Target validation
4.2.2.1 Target validation market, 2014 - 2025 (USD Million)
4.2.3 Lead identification
4.2.3.1 Lead identification market, 2014 - 2025 (USD Million)
4.2.4 Lead optimization
4.2.4.1 Lead optimization market, 2014 - 2025 (USD Million)
4.3 Preclinical
4.3.1 Preclinical market, 2014 - 2025 (USD Million)
4.4 Clinical
4.4.1 Clinical market, 2014 - 2025 (USD Million)
4.4.2 Phase I trial services
4.4.2.1 Phase I trial services market, 2014 - 2025 (USD Million)
4.4.3 Phase II trial services
4.4.3.1 Phase II trial services market, 2014 - 2025 (USD Million)
4.4.4 Phase III trial services
4.4.4.1 Phase III trial services market, 2014 - 2025 (USD Million)
4.4.5 Phase IV trial services
4.4.5.1 Phase IV trial services market, 2014 - 2025 (USD Million)
Chapter 5 Healthcare CRO Market: Service Estimates & Trend Analysis
5.1 Healthcare CRO Market: Service Movement Analysis
5.2 Competitive Landscape- Qualitative Analysis by Services
5.3 Project Management/Clinical Supply Management
5.3.1 Project management/clinical supply management market, 2014 - 2025 (USD Million)
5.4 Data Management
5.4.1 Data management market, 2014 - 2025 (USD Million)
5.5 Regulatory/Medical Affairs Outsourcing
5.5.1 Regulatory/medical affairs market, 2014 - 2025 (USD Million)
5.6 Medical Writing
5.6.1 Medical writing market, 2014 - 2025 (USD Million)
5.7 Clinical Monitoring
5.7.1 Clinical monitoring market, 2014 - 2025 (USD Million)
5.8 Quality Management/ Assurance
5.8.1 Quality management/assurance market, 2014 - 2025 (USD Million)
5.9 Biostatistics
5.9.1 Biostatistics market, 2014 - 2025 (USD Million)
5.10 Investigator Payments
5.10.1 Investigator payments market, 2014 - 2025 (USD Million)
5.11 Laboratory
5.11.1 Laboratory market, 2014 - 2025 (USD Million)
5.12 Patient and Site Recruitment
5.12.1 Patient and site recruitment market, 2014 - 2025 (USD Million)
5.13 Technology
5.13.1 Technology market, 2014 - 2025 (USD Million)
5.14 Others
5.14.1 Others market, 2014 - 2025 (USD Million)
Chapter 6 Healthcare CRO Market: Regional Estimates & Trend Analysis, by Type and Service
6.1 Healthcare CRO Market Share by Region, 2017 & 2025
6.2 North America
6.2.1 North America healthcare CRO market, 2014 - 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. healthcare CRO market, 2014 - 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Canada healthcare CRO market, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Europe healthcare CRO market, 2014 - 2025 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. healthcare CRO market, 2014 - 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Germany healthcare CRO market, 2014 - 2025 (USD Million)
6.3.4 France
6.3.4.1 France healthcare CRO market, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific healthcare CRO market, 2014 - 2025 (USD Million)
6.4.2 India
6.4.2.1 India healthcare CRO market, 2014 - 2025 (USD Million)
6.4.3 China
6.4.3.1 China healthcare CRO market, 2014 - 2025 (USD Million)
6.4.4 Japan
6.4.4.1 Japan healthcare CRO market, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America healthcare CRO market, 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil healthcare CRO market, 2014 - 2025 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico healthcare CRO market, 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 MEA healthcare CRO market, 2014 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa healthcare CRO market, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 IQVIA
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Service benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Covance Inc.
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Service benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Pharmaceutical Product Development, LLC (PPD)
7.2.3.1 Company overview
7.2.3.2 Service benchmarking
7.2.3.3 Strategic initiatives
7.2.4 PAREXEL
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Service benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Charles River Laboratories
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Service benchmarking
7.2.5.4 Strategic initiatives
7.2.6 ICON, Plc
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Service benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Medidata Solutions, Inc.
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Service benchmarking
7.2.7.4 Strategic initiatives
7.2.8 Syneos Health
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Service benchmarking
7.2.8.4 Strategic initiatives
7.2.9 Theorem Clinical Research
7.2.9.1 Company overview
7.2.10 Pharmaron
7.2.10.1 Company overview
7.2.10.2 Service benchmarking
7.2.10.3 Strategic initiatives
7.2.11 GVK Biosciences Private Limited
7.2.11.1 Company overview
7.2.11.2 Financial performance
7.2.11.3 Strategic initiatives
7.2.12 Dishman Carbogen Amics Limited
7.2.12.1 Company overview
7.2.12.2 Financial performance
7.2.12.3 Service benchmarking
7.2.12.4 Strategic initiatives
List of Tables
TABLE 1 Top specialty markets and their approximate spending, 2015
TABLE 2 Strategic partnership with pharmaceuticals
TABLE 3 Major acquisitions in the CRO market in 2016
TABLE 4 Outsourcing trend observed in small - medium - and large-scale companies
List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing &forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market summary 2017 (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Benefits of using robotic labs
FIG. 12 Areas of scope of improvement for CROs
FIG. 13 Pharmaceutical R&D spending 2007-2012 (USD Billion)
FIG. 14 Patients in clinical trials, 2015
FIG. 15 Market restraint relevance analysis (Current &future impact)
FIG. 16 Quality feedback from sponsors, 2011
FIG. 17 Penetration & growth prospect mapping
FIG. 18 Healthcare CRO market - PESTLE analysis
FIG. 19 Porter’s Five Forces Analysis
FIG. 20 Healthcare CRO market: Heat map analysis
FIG. 21 Healthcare Contract Research Organization (CRO) market share,2017
FIG. 22 Healthcare CRO market type outlook key takeaways
FIG. 23 Healthcare CRO market: Type movement analysis
FIG. 24 Global drug discovery market, 2014 - 2025 (USD Million)
FIG. 25 Global target validation market, 2014 - 2025 (USD Million)
FIG. 26 Lease identification market, 2014 - 2025 (USD Million)
FIG. 27 Lead optimization market, 2014 - 2025 (USD Million)
FIG. 28 Global preclinical market, 2014 - 2025 (USD Million)
FIG. 29 Global clinical market, 2014 - 2025 (USD Million)
FIG. 30 Phase I trial services market, 2014 - 2025 (USD Million)
FIG. 31 Phase II trial services market, 2014 - 2025 (USD Million)
FIG. 32 Phase III trial services market, 2014 - 2025 (USD Million)
FIG. 33 Phase IV trial services market, 2014 - 2025 (USD Million)
FIG. 34 Healthcare CRO service outlook key takeaways
FIG. 35 Healthcare CRO market: Service movement analysis
FIG. 36 Parameters for measuring success of provider solution
FIG. 37 Global project management/clinical supply management market, 2014 - 2025 (USD Million)
FIG. 38 Clinical data management flow
FIG. 39 Global data management market, 2014 - 2025 (USD Million)
FIG. 40 Global regulatory/medical affairs market, 2014 - 2025 (USD Million)
FIG. 41 Global medical writing market, 2014 - 2025 (USD Million)
FIG. 42 Global clinical monitoring market, 2014 - 2025 (USD Million)
FIG. 43 Global quality management/assurance market, 2014 - 2025 (USD Million)
FIG. 44 Global biostatistics market, 2014 - 2025 (USD Million)
FIG. 45 Global investigator payments market, 2014 - 2025 (USD Million)
FIG. 46 Global laboratory market, 2014 - 2025 (USD Million)
FIG. 47 Strategic initiatives with positive impact on patient recruitment
FIG. 48 Global patient and site recruitment market, 2014 - 2025 (USD Million)
FIG. 49 Global technology market, 2014 - 2025 (USD Million)
FIG. 50 Global others market, 2014 - 2025 (USD Million)
FIG. 51 Regional market place: Key takeaways
FIG. 52 Regional outlook, 2017 & 2025
FIG. 53 North America healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 54 U.S. healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 55 Canada healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 56 Europe healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 57 U.K. healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 58 Germany healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 59 France healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 60 Asia Pacific healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 61 India healthcare CRO Market, 2014 - 2025 (USD Million)
FIG. 62 China healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 63 Japan healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 64 Latin America healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 65 Brazil healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 66 Mexico healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 67 MEA healthcare CRO market, 2014 - 2025 (USD Million)
FIG. 68 South Africa healthcare CRO Market, 2014 - 2025 (USD Million)
FIG. 69 Strategy framework
FIG. 70 SWOT analysis
FIG. 71 SWOT analysis
FIG. 72 SWOT analysis
FIG. 73 SWOT analysis
FIG. 74 SWOT analysis
FIG. 75 SWOT analysis
FIG. 76 SWOT analysis
FIG. 77 SWOT analysis
FIG. 78 SWOT Analysis
FIG. 79 SWOT Analysis
FIG. 80 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report